Further investigation of spatial transcriptomics (ST) profiling (GSE238264) in immune-responsive and non-responsive HCC patients uncovered that LMNB2 expression was elevated in responders compared to non-responders (Fig. 1B and C). The gene discussed is LMNB2; the disease is hepatocellular carcinoma.